Table 1.
Model input | RCI | PMP or IVIg | Reference | ||
---|---|---|---|---|---|
Base case | Range | Base case | Range | ||
Total mean annual cost of care (2019 USD) | US$122,946 | US$107,462 to US$139,816 | US$126,412 | US$114,395 to US$139,816 | Gold, 201620 |
Inpatient costs | US$3688 | US$3224–4194 | US$10,013 | US$9061–11,075 | |
Outpatient costs | US$27,048 | US$23,642–30,760 | US$101,380 | US$91,743–112,130 | |
Medication costs | US$92,210 | US$80,597–104,862 | US$15,019 | US$13,591–16,612 | |
Weighted average response rate | 86.6% (n=377/435) | – | 49.9% (n=201/403) | – | |
Humana Comprehensive Health Insights Database | – | 96.9% (n=189/195) | – | 45.9% (n=112/244) | Nazareth, 201916 |
HealthCore Integrated Research Database | – | 78.3% (n=188/240) | – | 56.0% (n=89/159) | Nazareth, 201817 |
IVIg, intravenous immunoglobulin; PMP, plasmapheresis; RCI, repository corticotropin injection.